If you enjoy this content, please share it with a colleague
RELATED CONTENT
Technology
September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI.
News
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine receptor agonist approved for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress, requires infrequent use of the drug aminophylline to reverse its effect in the case of adverse events.